Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03551782
Title A Study of JNJ-63723283, a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | ESP | CAN | BEL

Facility Status City State Zip Country Details
University of California San Francisco (UCSF) - Prostate Cancer Center San Francisco California 94158-2350 United States Details
Regional Urology LLC Shreveport Louisiana 71106 United States Details
University of Michigan Health System Ann Arbor Michigan 48109-5000 United States Details
Washington University Bay Saint Louis Mississippi 63110 United States Details
New York University Langone Medical Center New York New York 10016 United States Details
Icahn School of Medicine at Mount Sinai - The Derald H. Ruttenberg New York New York 10029-6542 United States Details
Levine Cancer Institute, Carolinas HealthCare System Charlotte North Carolina 28204 United States Details
Centers for Advanced Urology, LLC; d/b/a MidLantic Urology Bala-Cynwyd Pennsylvania 19004 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
University of Texas, MD Anderson Cancer Center Houston Texas 77030 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
Grand Hôpital de Charleroi, site Notre Dame Charleroi 6000 Belgium Details
AZ Maria Middelares Gent 9000 Belgium Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
University of Toronto Toronto Ontario M5G 2M9 Canada Details
Centre de Recherche du CHUM Montreal Quebec H2X 0A9 Canada Details
Istituto Europeo di Oncologia Servizio Radioterapia Milano 20141 Italy Details
NKI-AVL, Amsterdam Amsterdam 1066 CX Netherlands Details
UMC Radboud Nijmegen 6525AG Netherlands Details
Sint Franciscus Gasthuis Rotterdam 3045 PM Netherlands Details
Moscow City Clinical Hospital # 62 Moscow 125130 Russian Federation Details
Hertzen Oncology Research Institute Moscow 125284 Russian Federation Details
Clinical Oncology Dispensary Omsk 644013 Russian Federation Details
Non-State Healthcare Institution 'Road Clinical Hospital of Russian Railways' Saint Petersburg 195271 Russian Federation Details
Russian Scientific Center of Radiology and Surgical Technologies Sankt-Peterburg 197758 Russian Federation Details
Hosp. Univ. Vall D Hebron Barcelona 8035 Spain Details
Hosp. Gral. Univ. Gregorio Marañon Madrid 28009 Spain Details
Hosp. Univ. Ramon Y Cajal Madrid 28034 Spain Details
Hosp. Univ. Fund. Jimenez Diaz Madrid 28040 Spain Details
Hosp. Univ. Hm Sanchinarro Madrid 28050 Spain Details
Hosp. Virgen de La Victoria Málaga 29010 Spain Details
Hosp. Quiron Madrid Pozuelo Pozuelo de Alarcon 28223 Spain Details
Hosp. Univ. Marques de Valdecilla Santander 39008 Spain Details
Instituto Valenciano de Oncologia Valencia 46009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field